Some key initiatives relegated to the PAAR due to lack of available funding

Cameroon’s 2017 TB/HIV funding request included a strong focus on communities and key populations. This was a key theme that emerged from the comments from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) when they reviewed the request.

On 1 December 2017, acting on the recommendation of the Global Fund’s Grant Approvals Committee (GAC), the Board approved two grants emanating from Thailand’s 2017 Window 2 TB/HIV funding request. The Ministry of Health’s Department of Disease Control will serve as principal recipient (PR) for one grant, totaling $18.0 million.

A report prepared for the Board meeting on 14-15 November in Geneva, Switzerland provided an update on the implementation of activities under the objectives and sub-objectives of the Global Fund’s 2017-2022 Strategy. For each sub-objective, the report described the progress achieved to date, as well as key challenges and risks, and future plans. In addition, the report identified the key performance indicator (KPI) tied to each sub-objective.

The two grants will expand case finding interventions, upgrade diagnostics and scale-up a public-private mix approach to TB

The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.

Secretariat decides to leave program split decision open until the RSSH proposal is received

Size of salary incentives linked to grant performance ratings

When it reviewed the funding requests from Benin, the Grant Approvals Committee (GAC) and the Technical Review Panel (TRP) expressed serious concerns about what they perceived as gaps in Benin’s HIV and malaria programs – which, they said, were partly due to the decision of the country coordinating mechanism (CCM) to shift some of its allocation towards an RSSH funding request.

The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.